person
Manfred W.
- Country
- Germany
- Department
- Onkologie
Research Overview
assignment
22
Clinical Trials ·
- A Comparative Study of ABP 234 and Pembrolizumab in Patients with Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
- Efficacy and Safety of PF-08634404 Plus Combination Therapy Versus Pembrolizumab Plus Combination Therapy in Adults With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
- Phase 2, multicenter, open‑label study of extended‑dosing belantamab mafodotin in combination therapy for relapsed/refractory multiple myeloma
Data & Insights
medical_services
Primary Speciality
Main therapeutic area
handshake
Return Partnerships
Recurring site collaborations
366
Sites with multiple studies
Has run more than one trial at 366 of 759 partner sites.
Specializations
Hematologic Oncology
The investigator has significant focus on treating various blood cancers and hematologic malignancies, with particular emphasis on novel therapeutic approaches.
- Chronic Lymphocytic Leukemia treatment with targeted therapies
- Acute Myeloid Leukemia management strategies
- Hodgkin Lymphoma advanced stage treatments
Solid Tumor Oncology
The investigator demonstrates extensive involvement in treating various solid tumors, particularly focusing on innovative therapeutic combinations.
- Breast Cancer with hormone receptor-positive status
- Non-small Cell Lung Cancer treatments
- Colorectal Cancer management
- Gastric Cancer interventions
Precision Medicine
The investigator specializes in targeted therapeutic approaches based on specific genetic and molecular markers.
- ESR1 mutation directed therapies
- HER2-negative disease management
- FLT3-ITD targeted approaches
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.